glutathione therapy for parkinson A Comprehensive Approach to Parkinson's Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects NAD IV Therapy and IV

65 Deficient CDO activity has been related to lower sulphate levels in plasma, elevated fasting plasma cysteine concentrations, and lower sulphate-conjugate:glucuronide-conjugate ratios for paracetamol detoxification products, consistent with impaired cysteine catabolism

European Journal of Clinical Pharmacology, [online] 43(6), pp.667669

other days, it can't be guaranteed, for reasons that have little to do with the dose itself

A 2002 study revealed that raising glutathione levels prolongs the patients pain-free walking distance, and improves local blood circulation

But if you want to give it a try, you can move ahead with your discretion, as it poses no threat to your skin and overall health